Evidence map›Paper›PMID 33884508›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021

Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences.

Alice Yu, Deborah Street, Rosalie Viney, Stephen Goodall, Alison Pearce, Philip Haywood, Marion Haas, Eva Battaglini, David Goldstein, Hannah Timmins and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Feasibility of clinical implementation and acceptability of patient-reported screening for chemotherapy-induced peripheral neuropathy (CIPN).Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Alice YuUniversity of Technology Sydney (CHERE), Sydney, NSW, Australia. alice.yu@chere.uts.edu.au.ORCID http://orcid.org/0000-0003-4515-9878
Deborah StreetUniversity of Technology Sydney (CHERE), Sydney, NSW, Australia.ORCID https://orcid.org/0000-0002-4476-0656
Rosalie VineyUniversity of Technology Sydney (CHERE), Sydney, NSW, Australia.ORCID https://orcid.org/0000-0002-0039-9635
Stephen GoodallUniversity of Technology Sydney (CHERE), Sydney, NSW, Australia.ORCID https://orcid.org/0000-0001-6611-6565
Alison PearceUniversity of Sydney (Sydney School of Public Health), Sydney, NSW, Australia.ORCID https://orcid.org/0000-0002-5690-9542
Philip HaywoodUniversity of Technology Sydney (CHERE), Sydney, NSW, Australia.ORCID https://orcid.org/0000-0001-5031-8648
Marion HaasUniversity of Technology Sydney (CHERE), Sydney, NSW, Australia.ORCID https://orcid.org/0000-0002-9726-3063
Eva BattagliniUniversity of New South Wales (Prince of Wales Clinical School), Sydney, NSW, Australia.ORCID https://orcid.org/0000-0001-9591-9930
David GoldsteinUniversity of New South Wales (Prince of Wales Clinical School), Sydney, NSW, Australia.
Hannah TimminsUniversity of Sydney, Sydney, NSW, Australia.ORCID https://orcid.org/0000-0001-5504-1625
Susanna B ParkBrain and Mind Centre, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.ORCID https://orcid.org/0000-0003-0218-4707
University of Technology Sydney · AUThe University of Sydney · AUUNSW Sydney · AU

Funding

National Health and Medical Research Council 1080521NHMRC Career Development Fellowship 1148595
6 · The paper itself

Abstract

purposeUp to 40% of cancer patients treated with neurotoxic chemotherapies experience chemotherapy-induced peripheral neuropathy (CIPN). Currently, there is no gold standard assessment tool for CIPN and there is little information in the literature on patient preferences for such assessments. This study aims to address this gap by identifying the features of a CIPN assessment tool that cancer patients value.

methodsAn online discrete choice experiment (DCE) survey of neurotoxic chemotherapy-treated patients was implemented. Respondents completed 8 choice questions each. In each choice question, they chose between two hypothetical CIPN assessment tools, each described by six attributes: impact on quality of life; level of nerve damage detected; questionnaire length; physical tests involved; impact on clinic time; impact on care.

resultsThe survey was completed by 117 respondents who had a range of cancers of which breast cancer was the most common. Respondents favoured an assessment tool that includes a physical test and that asks about impact on quality of life. Respondents were strongly opposed to clinicians, alone, deciding how the results of a CIPN assessment might influence their care especially their chemotherapy treatment. They were concerned about small changes in their CIPN, independent of clinical relevance. Respondents were willing to add half an hour to the usual clinic time to accommodate the CIPN assessment.

conclusionThe findings of this DCE will assist clinicians in choosing an assessment tool for CIPN that is satisfactory to both clinician and patient.

Indexed as

Antineoplastic AgentsBreast NeoplasmsPeripheral Nervous System DiseasesFemaleHumansPatient PreferenceQuality of LifeAntineoplastic AgentsChemotherapy-induced peripheral neuropathyCIPN assessment toolsDiscrete choice experimentPatient preferences

Identifiers

PMID33884508
OpenAlexW3156907340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.